Condition
Neuroendocrine Tumor GEP Grade 1-3 clinical trials and research
Research outlook What's coming for Neuroendocrine tumors: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Neuroendocrine Tumor GEP Grade 1-3 clinical trials that are recruiting, at sites in 2 countries (most in Canada (1), India (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
PRRT alone versus PRRT plus chemotherapy for gastroenteropancreatic neuroendocrine tumors
This test sees if adding capecitabine–temozolomide chemotherapy to Lutetium‑177 DOTATATE PRRT helps adults with advanced gastroenteropancreatic neuroendocrine tumors live longer without the cancer getting worse.
-
Quality of life after surgery for neuroendocrine tumors
This study looks at how surgery for neuroendocrine tumors affects the quality of life for patients to help improve their care after the operation.
Related topics
Quick answers
How many Neuroendocrine Tumor GEP Grade 1-3 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Canada (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.